Breast
Progress in genetic testing, such as BRCA1 and BRCA2 mutations, has transformed preventative strategies. Targeted therapies like HER2 inhibitors and advancements in hormone therapy have significantly improved survival rates.
New scanner can see ‘previously undetectable’ cancer spread, research suggests
A new scanner which can distinguish tumour material from healthy tissue more accurately than current methods could change the way breast cancer is diagnosed and treated, researchers have said.
Groundbreaking Trial Involving 700,000 Women Kicks Off After AI Predicts Breast Cancer Five Years Early
Thousands of women will participate in a study to see if AI could be used for early breast cancer detection. Around 700,000 women in the UK will take part in the AI breast cancer trial, according to the DHSC. Thirty testing sites will be involved in the study, each fitted with groundbreaking AI digital screening technology. Any woman who has already booked a routine breast cancer screening with NHS will be invited to participate in the study.
Cold therapy can reduce nerve pain in breast cancer patients
A new study led by researchers at the George Washington University Cancer Center has found that cold therapy, also known as cryotherapy, can help protect breast cancer patients from nerve pain caused by chemotherapy.
Having dense breasts is linked to cancer. But advice about breast density can depend on where you live
Having dense breasts is a clear risk factor for breast cancer. It can also make cancers hard to spot on mammograms.
KN026-Docetaxel Combo Shows Efficacy, Safety in HER2+ Metastatic Breast Cancer
KN026, a HER2-directed bispecific antibody, plus docetaxel achieved long-term response with manageable safety as a first line of therapy for patients with recurrent/metastatic HER2-positive breast cancer, as demonstrated by phase 2 trial (NCT04165993) results published in Cancer Communications
NHS launches first-ever breast screening campaign to help detect thousands of cancers earlier
Thousands more breast cancers could be detected earlier in England next year in a major new NHS drive to support more women to attend potentially life-saving breast screening.
Uncovering inequalities in breast cancer immunotherapy access
The study examines trends in immunotherapy treatment for triple-negative breast cancer since the new therapies were approved.
Immune response that may stop breast cancer from spreading identified
A new Moffitt Cancer Center study has identified a specific immune response that may prevent the spread of breast cancer cells within the body.
AI Contributes to Early Detection of Clinically Relevant Breast Cancer
THURSDAY, Feb. 13, 2025 (HealthDay News) — Artificial intelligence (AI) contributes to early detection of clinically relevant breast cancer, according to a study published online Feb. 3 in The Lancet Digital Health.
Scientists propose CDK2 enzyme as new target for cancer therapy
An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic resistance to common breast cancer drugs—including a class of targeted treatments known as CDK4/6 inhibitors.
Ultrasound imaging of breast cancer tumors offers noninvasive monitoring of treatment effectiveness
In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive method to track how tumors respond to radiation and immunotherapy, which uses the body’s own immune system to fight cancer.
New light-activated salt treatment targets aggressive breast cancer with precision
RIVERSIDE, Calif. — In the ongoing battle against aggressive breast cancer, light might become an unexpected ally.
